Non Invasive Glucose Monitoring Market
Non-Invasive Glucose Monitoring Market Forecasts to 2034 - Global Analysis By Technology (Optical Spectroscopy, Transdermal Technology, Electromagnetic Sensing, Fluorescence-based Monitoring, Bioimpedance Spectroscopy, Thermal Emission Technology, Saliva-based Glucose Monitoring, Tear-based Glucose Monitoring, and Breath-based Glucose Monitoring), Device Type, Product Type, Distribution Channel, Application, End User and By Geography
According to Stratistics MRC, the Global Non-Invasive Glucose Monitoring Market is accounted for $1.9 billion in 2026 and is expected to reach $12.4 billion by 2034, growing at a CAGR of 26.3% during the forecast period. Non-Invasive Glucose Monitoring refers to technologies designed to measure blood glucose levels without requiring skin puncture, capillary blood samples, or subcutaneous sensor insertion. This emerging market spans optical spectroscopy methods including near-infrared and Raman spectroscopy, transdermal sensing, electromagnetic technologies, bioimpedance spectroscopy, and body fluid-based detection approaches utilizing saliva, tears, and exhaled breath.
Market Dynamics:
Driver:
Rapid growth in global diabetes prevalence demanding comfortable, continuous glucose monitoring
The global diabetes epidemic, with projections exceeding 780 million affected individuals by 2045, creates an enormous addressable market for non-invasive glucose monitoring solutions. Patient compliance with blood glucose monitoring is significantly compromised by the pain, inconvenience, and cost associated with traditional fingerstick and invasive continuous glucose monitoring systems. Non-invasive approaches eliminate needle-based barriers, enabling more frequent monitoring, improved glycemic control, and reduced long-term diabetes complications. Wearable technology adoption trends and growing consumer interest in metabolic health among non-diabetic wellness-conscious individuals further expand the potential user base beyond clinically diagnosed patients.
Restraint:
Formidable technical accuracy challenges hindering regulatory clearance
Achieving clinically acceptable measurement accuracy comparable to invasive reference methods remains the fundamental scientific and engineering obstacle for non-invasive glucose monitoring developers. Glucose signals in optical and electromagnetic modalities are confounded by factors including skin hydration, temperature, pressure application variability, tissue heterogeneity, and interfering substances with overlapping spectral signatures. Regulatory agencies including the FDA require prospective clinical validation studies demonstrating performance within the ISO 15197 accuracy standard across diverse patient populations and physiological conditions. Multiple well-funded development programs have failed to achieve regulatory clearance, creating investor skepticism and slowing commercialization.
Opportunity:
Wearable technology convergence enabling glucose monitoring within consumer health platforms
The integration of non-invasive glucose sensing into mainstream consumer wearable platforms, including smartwatches, fitness bands, and biosensor patches, represents a transformative commercial opportunity. Major consumer electronics manufacturers are actively developing on-device glucose monitoring capabilities that would embed glucose data into broader health dashboards alongside heart rate, blood oxygen, and sleep metrics. Successfully commercializing wearable-integrated glucose monitoring would exponentially expand the addressable market beyond clinical diabetes management into the vast wellness and preventive health consumer segment, supported by app ecosystems providing personalized metabolic health coaching and dietary guidance.
Threat:
Intense competition from advanced minimally invasive CGM systems
The continuous improvement of minimally invasive continuous glucose monitoring systems, including Abbott's FreeStyle Libre and Dexcom's G-series platforms, raises the performance benchmark that non-invasive alternatives must match or surpass to achieve clinical adoption. These established systems offer factory-calibrated accuracy, multi-day wear duration, and seamless smartphone integration, creating a high competitive bar. The significant installed user base, established reimbursement frameworks, and strong physician familiarity with minimally invasive CGM systems present substantial switching cost barriers for non-invasive entrants, even after achieving regulatory clearance with acceptable accuracy profiles.
Covid-19 Impact
COVID-19 amplified interest in non-invasive glucose monitoring by highlighting the vulnerability of diabetic patients to severe disease outcomes and the practical difficulties of maintaining blood glucose monitoring routines during pandemic isolation. Reduced access to clinical settings increased reliance on home monitoring solutions, reinforcing demand for easier, more comfortable glucose measurement approaches. The pandemic also accelerated digital health investment, including funding for non-invasive glucose monitoring startups pursuing breakthrough sensing technologies. Post-pandemic, sustained consumer health awareness and growing wellness monitoring market segments continue to attract investment and commercial development activity in non-invasive glucose sensing.
The Wearable Devices segment is expected to be the largest during the forecast period
Wearable devices represent the largest device type segment in the non-invasive glucose monitoring market, reflecting consumer preference for continuous, on-body health monitoring solutions integrated into everyday routines. Wristband and patch form factors that enable passive, real-time glucose trend monitoring are particularly attractive for both diabetic and wellness-focused user segments. The convergence of glucose sensing with established wearable health device categories including smartwatches and fitness trackers benefits from existing consumer adoption infrastructure.
The Optical Spectroscopy Technology segment is expected to have the highest CAGR during the forecast period
Optical spectroscopy, particularly near-infrared and Raman spectroscopy approaches, is expected to register the highest CAGR among non-invasive glucose monitoring technologies, driven by ongoing advances in miniaturized photonic components, signal processing algorithms, and machine learning-based calibration techniques. Multiple companies pursuing optical spectroscopy pathways have demonstrated encouraging clinical accuracy improvements in recent validation studies, attracting significant venture capital and corporate investment.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, North America holds the largest share of the non-invasive glucose monitoring market, supported by the highest global concentration of diabetes technology investment, established regulatory pathways for novel glucose monitoring devices, and a substantial diabetic patient population with demonstrated willingness to adopt innovative monitoring solutions. The United States venture capital ecosystem has provided extensive funding to non-invasive glucose monitoring startups, enabling prolonged research and clinical validation programs.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Asia Pacific is projected to achieve the highest CAGR in the non-invasive glucose monitoring market, driven by China's position as the world's largest diabetic population, India's rapidly growing diabetes burden, and Japan's advanced wearable technology manufacturing ecosystem. Significant unmet clinical need in markets with limited healthcare access is driving strong demand for affordable, convenient glucose monitoring alternatives. Regional technology companies are actively developing non-invasive glucose solutions tailored to Asian populations, supported by government health digitization programs and expanding domestic medical device.
Key players in the market
Some of the key players in Global Non-Invasive Glucose Monitoring Market include Abbott Laboratories, Dexcom Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, Integrity Applications Inc., Know Labs Inc., Movano Health, Nemaura Medical Inc., GlucoTrack Inc., Afon Technology Ltd., Cnoga Medical Ltd., PKvitality, Biolinq Incorporated, DiaMonTech AG, and Hagar hf.
Key Developments:
In March 2026, Know Labs reported positive interim results from an expanded clinical accuracy validation study of its radio frequency-based non-invasive glucose monitoring technology, demonstrating performance approaching ISO 15197 standard thresholds across a diverse patient cohort, advancing the company's regulatory submission timeline toward an anticipated FDA de novo authorization pathway.
In January 2026, Movano Health announced the initiation of a pivotal clinical study for its wearable ring-based non-invasive glucose monitoring platform, enrolling participants across multiple clinical sites to generate the prospective real-world accuracy data required to support a formal FDA premarket submission for its biosensor technology.
Technologies Covered:
• Optical Spectroscopy
• Transdermal Technology
• Electromagnetic Sensing
• Fluorescence-based Monitoring
• Bioimpedance Spectroscopy
• Thermal Emission
• Saliva/Tear/Breath-based
Device Types Covered:
• Wearable Devices
• Handheld Devices
• Sensor-based Devices
• Smartphone-integrated Devices
Product Types Covered:
• CGM Devices
• Flash Glucose Monitoring
• Real-time Monitoring Systems
• Integrated Diabetes Management Platforms
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Direct Sales
• Specialty Diabetes Care Stores
Applications Covered:
• Diabetes Management
• Prediabetes Monitoring
• Fitness & Wellness Monitoring
• Hospital Glucose Monitoring
• Home Healthcare Monitoring
End Users Covered:
• Hospitals
• Clinics & Diabetes Centers
• Home Care Settings
• Ambulatory Surgical Centers
• Research Institutes
• Sports & Fitness Users
• Other End Users
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Non-Invasive Glucose Monitoring Market, By Technology
5.1 Optical Spectroscopy
5.1.1 Near-Infrared Spectroscopy
5.1.2 Raman Spectroscopy
5.1.3 Photoacoustic Spectroscopy
5.1.4 Optical Coherence Tomography
5.2 Transdermal Technology
5.3 Electromagnetic Sensing
5.4 Fluorescence-based Monitoring
5.5 Bioimpedance Spectroscopy
5.6 Thermal Emission Technology
5.7 Saliva-based Glucose Monitoring
5.8 Tear-based Glucose Monitoring
5.9 Breath-based Glucose Monitoring
6 Global Non-Invasive Glucose Monitoring Market, By Device Type
6.1 Wearable Devices
6.2 Handheld Devices
6.3 Sensor-based Devices
6.4 Smartphone-integrated Devices
7 Global Non-Invasive Glucose Monitoring Market, By Product Type
7.1 Continuous Glucose Monitoring (CGM) Devices
7.2 Flash Glucose Monitoring Devices
7.3 Real-time Monitoring Systems
7.4 Integrated Diabetes Management Platforms
8 Global Non-Invasive Glucose Monitoring Market, By Distribution Channel
8.1 Hospital Pharmacies
8.2 Retail Pharmacies
8.3 Online Pharmacies
8.4 Direct Sales
8.5 Specialty Diabetes Care Stores
9 Global Non-Invasive Glucose Monitoring Market, By Application
9.1 Diabetes Management
9.2 Prediabetes Monitoring
9.3 Fitness & Wellness Monitoring
9.4 Hospital Glucose Monitoring
9.5 Home Healthcare Monitoring
10 Global Non-Invasive Glucose Monitoring Market, By End User
10.1 Hospitals
10.2 Clinics & Diabetes Centers
10.3 Home Care Settings
10.4 Ambulatory Surgical Centers
10.5 Research Institutes
10.6 Sports & Fitness Users
10.7 Other End Users
11 Global Non-Invasive Glucose Monitoring Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa
12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment
13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives
14 Company Profiles
14.1 Abbott Laboratories
14.2 Dexcom, Inc.
14.3 Medtronic plc
14.4 F. Hoffmann-La Roche Ltd
14.5 Integrity Applications Inc.
14.6 Know Labs, Inc.
14.7 Movano Health
14.8 Nemaura Medical Inc.
14.9 GlucoTrack, Inc.
14.10 Afon Technology Ltd.
14.11 Cnoga Medical Ltd.
14.12 PKvitality
14.13 Biolinq Incorporated
14.14 DiaMonTech AG
14.15 Hagar hf.
List of Tables
1 Global Non-Invasive Glucose Monitoring Market Outlook, By Region (2023-2034) ($MN)
2 Global Non-Invasive Glucose Monitoring Market Outlook, By Technology (2023-2034) ($MN)
3 Global Non-Invasive Glucose Monitoring Market Outlook, By Optical Spectroscopy (2023-2034) ($MN)
4 Global Non-Invasive Glucose Monitoring Market Outlook, By Near-Infrared Spectroscopy (2023-2034) ($MN)
5 Global Non-Invasive Glucose Monitoring Market Outlook, By Raman Spectroscopy (2023-2034) ($MN)
6 Global Non-Invasive Glucose Monitoring Market Outlook, By Photoacoustic Spectroscopy (2023-2034) ($MN)
7 Global Non-Invasive Glucose Monitoring Market Outlook, By Optical Coherence Tomography (2023-2034) ($MN)
8 Global Non-Invasive Glucose Monitoring Market Outlook, By Transdermal Technology (2023-2034) ($MN)
9 Global Non-Invasive Glucose Monitoring Market Outlook, By Electromagnetic Sensing (2023-2034) ($MN)
10 Global Non-Invasive Glucose Monitoring Market Outlook, By Fluorescence-based Monitoring (2023-2034) ($MN)
11 Global Non-Invasive Glucose Monitoring Market Outlook, By Bioimpedance Spectroscopy (2023-2034) ($MN)
12 Global Non-Invasive Glucose Monitoring Market Outlook, By Thermal Emission Technology (2023-2034) ($MN)
13 Global Non-Invasive Glucose Monitoring Market Outlook, By Saliva-based Glucose Monitoring (2023-2034) ($MN)
14 Global Non-Invasive Glucose Monitoring Market Outlook, By Tear-based Glucose Monitoring (2023-2034) ($MN)
15 Global Non-Invasive Glucose Monitoring Market Outlook, By Breath-based Glucose Monitoring (2023-2034) ($MN)
16 Global Non-Invasive Glucose Monitoring Market Outlook, By Device Type (2023-2034) ($MN)
17 Global Non-Invasive Glucose Monitoring Market Outlook, By Wearable Devices (2023-2034) ($MN)
18 Global Non-Invasive Glucose Monitoring Market Outlook, By Handheld Devices (2023-2034) ($MN)
19 Global Non-Invasive Glucose Monitoring Market Outlook, By Sensor-based Devices (2023-2034) ($MN)
20 Global Non-Invasive Glucose Monitoring Market Outlook, By Smartphone-integrated Devices (2023-2034) ($MN)
21 Global Non-Invasive Glucose Monitoring Market Outlook, By Product Type (2023-2034) ($MN)
22 Global Non-Invasive Glucose Monitoring Market Outlook, By Continuous Glucose Monitoring (CGM) Devices (2023-2034) ($MN)
23 Global Non-Invasive Glucose Monitoring Market Outlook, By Flash Glucose Monitoring Devices (2023-2034) ($MN)
24 Global Non-Invasive Glucose Monitoring Market Outlook, By Real-time Monitoring Systems (2023-2034) ($MN)
25 Global Non-Invasive Glucose Monitoring Market Outlook, By Integrated Diabetes Management Platforms (2023-2034) ($MN)
26 Global Non-Invasive Glucose Monitoring Market Outlook, By Distribution Channel (2023-2034) ($MN)
27 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
28 Global Non-Invasive Glucose Monitoring Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
29 Global Non-Invasive Glucose Monitoring Market Outlook, By Online Pharmacies (2023-2034) ($MN)
30 Global Non-Invasive Glucose Monitoring Market Outlook, By Direct Sales (2023-2034) ($MN)
31 Global Non-Invasive Glucose Monitoring Market Outlook, By Specialty Diabetes Care Stores (2023-2034) ($MN)
32 Global Non-Invasive Glucose Monitoring Market Outlook, By Application (2023-2034) ($MN)
33 Global Non-Invasive Glucose Monitoring Market Outlook, By Diabetes Management (2023-2034) ($MN)
34 Global Non-Invasive Glucose Monitoring Market Outlook, By Prediabetes Monitoring (2023-2034) ($MN)
35 Global Non-Invasive Glucose Monitoring Market Outlook, By Fitness & Wellness Monitoring (2023-2034) ($MN)
36 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospital Glucose Monitoring (2023-2034) ($MN)
37 Global Non-Invasive Glucose Monitoring Market Outlook, By Home Healthcare Monitoring (2023-2034) ($MN)
38 Global Non-Invasive Glucose Monitoring Market Outlook, By End User (2023-2034) ($MN)
39 Global Non-Invasive Glucose Monitoring Market Outlook, By Hospitals (2023-2034) ($MN)
40 Global Non-Invasive Glucose Monitoring Market Outlook, By Clinics & Diabetes Centers (2023-2034) ($MN)
41 Global Non-Invasive Glucose Monitoring Market Outlook, By Home Care Settings (2023-2034) ($MN)
42 Global Non-Invasive Glucose Monitoring Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
43 Global Non-Invasive Glucose Monitoring Market Outlook, By Research Institutes (2023-2034) ($MN)
44 Global Non-Invasive Glucose Monitoring Market Outlook, By Sports & Fitness Users (2023-2034) ($MN)
45 Global Non-Invasive Glucose Monitoring Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
